Bayer plans to focus on Life Science businesses

18 September 2014 - Deborah Wilkes

Archived

Bayer plans to float its MaterialScience business on the stock market as a separate company, leaving it free to focus on its Life Science businesses.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: